News & Analysis on Clinical Trial Services & Contract Research And Development
A diagnostic test, which monitors anti-HIV drugs in the blood, is set to enter development to eventually become available across Europe. The test will be used to identify the correct dosage of medicine for individual patients.
A Phase I clinical trial, which is investigating the pharmacological activities of a compound for the treatment of Alzheimer's disease, has just been completed with results indicating improved efficacy and pharmacokinetics over its predecessor.
An affirmation that aims to replace the use of laboratory animals in testing was agreed in Brussels by key industry sectors representing the European chemical, pharmaceutical and biotechnology industries.
Contract research specialists Xceleron have announced a new three-year deal that provides support for GSK's bioanalytical AMS programme for human metabolite profiling and obtaining mass balance data.
Biochip technology has redefined the process of drug discovery with partnerships central to accelerating adoption levels and expanding revenues in a market that is reinforced by strong bioinformatics infrastructure and standardisation of array platforms.